EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes

Sanofi65 enrolled

Overview

Study objective: * To demonstrate, in patients with myofascial pain syndrome in cervical region, the degree of efficacy of thiocolchicoside ointment administered to trigger point regions compared with the trigger point injection.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Myofascial Pain Syndromes

Interventions

ThiocolchicosideDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Submitted to clinic with a complaint of head and neck pain * Be diagnosed as having myofascial pain syndrome by determining the active trigger points in trapezius and/or interscapular region according to criteria of Simons and Travel * Have 1 to 8 active trigger point(s) Exclusion Criteria: * Have evident cervical discopathy and signs of osteoarthritis * Have bleeding diathesis or using anticoagulant medication which hinders injection * Have known malignity, being used steroids, have immunodepressive disorders and/or being taken immunodepressive drugs * Be pregnant or have the possibility of being pregnant or not being used a regular contraceptive method * Have known allergic reaction against Thiocolchicoside

Locations (1)

Sanofi-Aventis

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Pain relief (Visual Analog Scale and sensitometer) and increase in mobility of neck. Patient and physician satisfaction

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.